Table 1.

Corrected disclosures (corrections are bolded)

AuthorOriginal DisclosuresCorrected Disclosures
Edmund HuangE.H. has no disclosures to report.E.H. has no disclosures to report.
Stanley C. JordanS.C.J. received grant support from Hansa Medical and is a consultant for Hansa Medical.S.C.J. reports grants from Hansa Medical, during the conduct of the study; grants and personal fees from Hansa Medical; grants, personal fees, and other from CSL Behring, grants and personal fees from Vitaeris; and grants from Genentech, outside the submitted work. In addition, Dr. Jordan has a patent Imlifidase + Rituximab for Desensitization pending, a patent anti-IL-6 for treatment of ABMR pending, and a patent C1INH for prevention of DGF pending.